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Strengths and limitations of this study
 ► A systematic approach to assess stakeholder en-
gagement in systematic and rapid reviews was 
used to fill the gap and to provide an overview of the 
current situation.
 ► The different review types were able to inform on 
stakeholder involvement and pointed to potential 
improvements.
 ► With the scope of this study being restricted to 
health services research we intended to focus on a 
best-case approach where the context is considered 
most important and therefore, stakeholder involve-
ment might be most regularly, but the overall find-
ings might not be applicable beyond this domain.
 ► The majority of studies were from high-income 
countries limiting the generalisability beyond this 
setting.
 ► The perception and the reporting of stakeholder in-
volvement might be influenced by the lack of a uni-
form definition of stakeholders and depend on the 
criteria used.
ABSTRACT
Objective Engaging stakeholders in reviews is considered 
to generate more relevant evidence and to facilitate 
dissemination and use. As little is known about stakeholder 
involvement, we assessed the characteristics of their 
engagement in systematic and rapid reviews and the 
methodological quality of included studies. Stakeholders 
were people with a particular interest in the research topic.
Design Methodological review.
Search strategy Four databases (Medline, Embase, 
Cochrane database of systematic reviews, databases 
of the University of York, Center for Reviews and 
Dissemination (CRD)) were searched based on an a 
priori protocol. Four types of reviews (Cochrane and 
non-Cochrane systematic reviews, rapid and CRD rapid 
reviews) were retrieved between January 2011 and 
October 2015, pooled by potential review type and 
duplicates excluded. Articles were randomly ordered 
and screened for inclusion and exclusion criteria until 30 
reviews per group were reached. Their methodological 
quality was assessed using AMSTAR and stakeholder 
characteristics were collected.
Results In total, 57 822 deduplicated citations were 
detected with potential non-Cochrane systematic reviews 
being the biggest group (56 986 records). We found 
stakeholder involvement in 13% (4/30) of Cochrane, 
20% (6/30) of non-Cochrane, 43% (13/30) of rapid and 
93% (28/30) of CRD reviews. Overall, 33% (17/51) of the 
responding contact authors mentioned positive effects of 
stakeholder involvement. A conflict of interest statement 
remained unmentioned in 40% (12/30) of non-Cochrane 
and in 27% (8/30) of rapid reviews, but not in Cochrane 
or CRD reviews. At most, half of non-Cochrane and rapid 
reviews mentioned an a priori study protocol in contrast to 
all Cochrane reviews.
Conclusion Stakeholder engagement was not general 
practice, except for CRD reviews, although it was more 
common in rapid reviews. Reporting factors, such as 
including an a priori study protocol and a conflict of 
interest statement should be considered in conjunction 
with involving stakeholders.
InTRODuCTIOn
Evidence synthesis remains a rapidly growing 
field. There are different methodological 
approaches and formats depending on the 
research question and the intended use of the 
review, such as scoping, systematic or rapid 
reviews as well as realist syntheses, policy briefs 
and health technology assessments (HTAs). 
We will focus on full systematic reviews as 
a well-established review type in health-
care and on rapid reviews as an emerging 
one. A traditional full systematic review is a 
review that ‘attempts to collate all empirical 
evidence and that fits prespecified eligibility 
criteria in order to answer a specific, usually 
narrow research question or intervention’.1 
Within systematic reviews, Cochrane full 
systematic reviews were established as ‘gold 
standard’ in knowledge synthesis. A couple 
of studies compared Cochrane and non-Co-
chrane systematic reviews and found that the 
reporting of Cochrane systematic reviews was 
the most complete one,2 that they were less 
prone to bias due to greater transparency in 
reporting as well as due to the quality criteria 
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used, such as the risk of bias assessment.3 Furthermore, 
Hopewell et al described that the inclusion of grey litera-
ture routinely performed in Cochrane systematic reviews 
limited publication bias and provided more conservative 
treatment effects compared with non-Cochrane system-
atic reviews without including grey literature.4
Rapid reviews are characterised by a less complex 
research question and aim to synthesise evidence within 
a shorter time period, with time frames ranging from 1 
week to 9 months.5 6 They might, therefore, be prone to 
be of lower validity as a consequence of accelerating and 
streamlining the review process.5 However, in response to 
an increasing demand from stakeholders, rapid reviews 
are being performed more frequently than before.6 Only 
few formal definitions of different rapid reviews exist and 
few studies have examined their methodology.7 To cover 
the variety of rapid reviews we included rapid reviews listed 
in medical databases as well as other rapid reviews from 
the databases of the University of York, Center for Reviews 
and Dissemination ( www. crd. york. ac. uk/ CRDWeb), such 
as the Dare reviews (Database of Abstracts of Reviews 
of Effects) or HTAs (CRD rapid reviews). Rapid reviews 
target specific audiences including government policy-
makers, healthcare institutions, health professionals and 
patient associations and research questions are often 
tailored to these stakeholders .8 9
Stakeholder as a very broad term may include anyone 
affected by an issue and/or anyone who can provide input 
on the topic.10 11 Hence, not only decision makers, health 
professionals and their organisations are targeted, but 
also citizen or patients, other researchers and the media. 
Involving stakeholders in health services research might 
be possible at all stages of systematic or rapid reviews and 
this is often referred to as co-production. Thus, stake-
holder engagement aims participatory research and 
might direct the research question, define the scope and 
context of the review as well as contribute to the litera-
ture search, the evidence synthesis and interpretation 
and might facilitate dissemination and use. Therefore, it 
enhances the relevance of findings for policy and practice 
and contributes to the sustainability of health systems.12–14 
We especially focused on stakeholder involvement among 
health services research. This embraced 'the multi-
disciplinary field of scientific studies regarding social, 
financing and personal factors, organisational structures 
and processes, health technologies, and how these factors 
affect access to, the quality and cost of healthcare, and 
ultimately, our health and well-being’.15 Here, we consid-
ered the context of conducted studies and dissemination 
issues as most important, and we expected health services 
research to be the research field where stakeholders were 
involved most regularly.
Study aim
To date, little is known about the extent of stakeholder 
engagement in systematic and rapid reviews and there 
have been few efforts to directly report the specific effects 
regarding their involvement. We consider this information 
to be relevant for integrated knowledge translation, the 
dissemination and acceptance of systematic and rapid 
reviews in policy and practice. We focused on systematic 
and rapid reviews as they represent different types of 
evidence synthesis and are well-established in research 
and practice. In addition, reviews needed to belong to 
the area of health services research as an established 
field for systematic and rapid reviews as well as a best-case 
sample with a considerable extent of stakeholder involve-
ment. We aimed to assess the extent and characteristics 
of stakeholder engagement in published systematic and 
rapid reviews and to specifically determine reporting 
characteristics.
MeThODS
Study design
Based on the prespecified protocol this methodolog-
ical review was performed to assess characteristics and 
reporting of stakeholder engagement in random samples 
of systematic and rapid reviews in the field of health 
services research (online supplementary file S1). A total 
of four types of reviews, two groups of each, systematic 
and rapid reviews, were assessed as they were consid-
ered to exhibit potentially differences in stakeholder 
involvement. This included Cochrane systematic reviews, 
non-Cochrane systematic reviews, rapid reviews and rapid 
reviews of the databases of the University of York, CRD 
rapid reviews. For the reporting of this study the Preferred 
Reporting Items for Systematic Reviews and Meta-Anal-
yses (PRISMA) checklist was used (online supplementary 
file S2).
Search strategy and screening
For systematic reviews, we searched the Cochrane data-
base of systematic reviews for articles including the term 
‘systematic review’ in their title or abstract (Cochrane 
systematic reviews) and EBSCO Medline and Embase 
with excluding the term ‘Cochrane’ in title or abstract 
(non-Cochrane systematic reviews). Rapid reviews were 
searched in EBSCO Medline and Embase and in the 
databases of the University of York, CRD rapid reviews ( 
www. crd. york. ac. uk/ CRDWeb). Sample search strategies 
are depicted in online supplementary files S3a and S3b. 
We included studies published between January 2011 and 
December 2015 without language restriction. Our search 
was completed on 22 October 2015 and therefore, the 
search results for 2015 did not cover the whole year. All 
results were pooled by review type and duplicates were 
excluded based on authors, journal and publication year. 
For each of the four lists of potential study types, each 
reference was given a unique random number using the 
sample() function available in R.16 Each list was then 
sorted by the random number, and the articles were 
screened in order for inclusion and exclusion criteria by 
two reviewers until a total of 30 studies were reached per 
group (JF and MM tested their consistency in assessing 
the inclusion and exclusion criteria for about 10 different 
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studies and MM checked the assignment for about half of 
the study sample). Full text screening was performed to 
ensure the decision. One review author (JF) performed 
data extraction, supervised and spot-checked by a second 
researcher (MM). Disagreements were resolved by 
consensus.
Sample size and selection of review groups
As rapid reviews were often targeted to specific audi-
ences,8 9 they were expected to involve stakeholders to a 
greater extent. We estimated a proportion of stakeholder 
involvement of 0.70 for rapid reviews and of 0.25 for 
systematic reviews, which resulted in a minimal expected 
difference of 0.45. For a two group-comparison, rapid 
and systematic reviews, with n=25 per group there will 
be an estimated power of 0.88 and an alpha of 0.023. To 
account for a potential subgroup analysis, we included 
a sample of n=30 reviews per group, with four review 
groups (Cochrane and non-Cochrane systematic reviews, 
rapid and CRD rapid reviews). This resulted in an overall 
sample of 120 studies.
Inclusion and exclusion criteria
We included reviews targeting health services research 
as defined by Lohr15: “Health services research is the 
multidisciplinary field of scientific investigation that 
studies how social factors, financing systems, organiza-
tional structures and processes, health technologies, 
and personal behaviors affect access to health care, the 
quality and cost of health care, and ultimately, our health 
and well-being. Its research domains are individuals, 
families, organizations, institutions, communities, and 
populations”. Therefore, we included HTAs (eg, rapid 
reviews as part of HTAs) targeting effectiveness as well as 
meta-analyses and systematic reviews for effectiveness and 
utility, reviews of pharmaceutical trials under everyday 
conditions, reviews of basic research in care-related fields, 
reviews of quality research or of methodological devel-
opments in the field of health services research, reviews 
about the development and application of new technol-
ogies (ehealth) and the implementation of knowledge 
into clinical practice. We excluded reviews that focused 
exclusively on economic or cost analyses, performed a 
narrative review, an overview of reviews or a protocol of 
a systematic review in order not to mix so different meth-
odological approaches. The following study types were 
also excluded: reviews of efficacy studies without assessing 
the quality of life, reviews including clinical efficacy trials 
phase I–III, epidemiological reviews to assess determi-
nants or risk factors, non-human studies, establishment 
of databases or registries, reviews with unclear design or 
description of the intervention.
Data extraction
Stakeholders were defined as people with a particular 
interest in the research topic (but were not members of 
the primary research team).10 17 We evaluated any kind of 
stakeholder involvement and recorded different groups 
of stakeholders: institutional healthcare providers, repre-
sentatives of hospitals or community services, patients/
consumers, participants of government agencies and 
healthcare policymakers at Federal, State and local levels, 
associations of health professionals and researchers (if 
not members of the primary study team). If available, we 
identified their fields and stages of involvement as well as 
their contribution to the study. This included all review 
steps, such as formulating the research question(s), deter-
mining study characteristics, contributing to the writing 
of the protocol, participating within the review process 
with searching, screening, data extraction, synthesising, 
interpreting the study results and/or establishing recom-
mendations. In addition, we extracted the following data: 
institution where the review was performed, contact 
details of the corresponding author, the type of inter-
vention, study setting, characteristics of the population 
(sample size, age range, sex), funding, declared conflict of 
interest, year of publication. The methodological quality 
of included articles was assessed using the AMSTAR tool, 
a measurement tool for the assessment of the method-
ological quality of systematic reviews.18 Where available, 
our rating was compared with an already existing one 
from the ‘health evidence’ or ‘health systems evidence’ 
platforms.19 20 Both quality ratings were then categorised 
as strong (≥8), moderate (4–7) or weak (<4). In the 
absence of a quality assessment tool for rapid reviews, we 
used AMSTAR also for rapid reviews, being aware that 
this might result in lower rating scores due to abbreviated 
procedures. In addition, the use of the PRISMA checklist 
was recorded when mentioned in the articles.21 AMSTAR 
ratings are presented as online supplementary file S4, 
study characteristics as online supplementary file S5.
To ascertain stakeholder engagement as well as to assess 
the extent or stages of their involvement, preformulated 
questions were sent by email to the contact authors of the 
included articles. We asked them, if there had been any 
stakeholder involvement (yes or no) and if so, to specify 
the number of stakeholders, the stages of involvement 
and their self-assessed estimation of the effect of stake-
holder engagement on the review outcome. In case of 
missing responses, one reminder was sent.
Patient and Public involvement
None involved.
ReSulTS
Our search identified 57 822 citations remaining after 
exclusion of duplicates. Although, not all of these records 
will fulfil the inclusion criteria, such as for example, 
being designed as a systematic review, we assigned them 
as potential review group. For the screening step, the 
counts of the articles that needed to be screened to reach 
the final set of studies are depicted in figure 1.22–141 The 
excluded studies are presented in online supplementary 
table S1.
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Figure 1 Flow diagram of study selection. CRD, 
databases of the University of York, Centre for Reviews and 
Dissemination; RR, rapid review; SR, systematic review.
Table 1 presents the characteristics of the included 
studies. Cochrane systematic reviews generally focused 
on the prevention and treatment of specific condi-
tions, whereas 30% of non-Cochrane systematic reviews 
were categorised with a community-based topic, with a 
wide range of participants and possible outcomes and a 
broader range of study settings. Of note, 23% of each, 
rapid reviews and CRD rapid reviews, were categorised 
as health system intervention, because they focused on 
methodological questions or health quality research.
We detected noticeable differences when comparing 
the median AMSTAR scores: Cochrane systematic reviews 
and CRD rapid reviews showed higher median scores 
than non-Cochrane systematic reviews and rapid reviews. 
Where available, we also collected existing AMSTAR 
ratings from the ‘health evidence’ or ‘health systems 
evidence’ platforms. For 68% (13/19 study ratings) we 
found a congruent classification as strong, moderate or 
weak, respectively (online supplementary file S4). In 
non-Cochrane reviews information about methodological 
specifications of included studies were often lacking. As 
an example, all 30 Cochrane systematic reviews (100%) 
mentioned a pre-existing review protocol, whereas a high 
amount of non-Cochrane systematic reviews (59%) and 
of rapid reviews (43%) did not clarify whether there had 
been a protocol or not. Similarly, all 30 Cochrane system-
atic reviews and all but one CRD rapid reviews (97%) 
included a conflict of interest statement, whereas 40% 
of non-Cochrane systematic reviews and 27% of rapid 
reviews lacked such a paragraph. All reviews were funded 
by national or international governmental or institutional 
sources. Only one rapid review reported the acceptance 
of additional funding from a pharmaceutical company.
Characteristics of the study population by type of 
included review are presented in online supplementary 
table S2.
Any stakeholder involvement was mentioned in 13% 
of Cochrane systematic reviews, 20% of non-Cochrane 
systematic reviews, 43% of rapid reviews and 93% of CRD 
rapid reviews. Except for CRD rapid reviews, where the 
involvement of stakeholders was routinely reported in 
the methods or appendix section, about half of the stake-
holder involvement was reported in the articles and the 
other half was confirmed via email by contact authors 
and remained unmentioned in the reviews. With 67% the 
email response rate was highest for rapid reviews. When 
comparing the amount of stakeholder involvement in 
different review topics, there were notable differences: the 
proportion of stakeholder involvement in reviews focusing 
on prevention or treatment of specific conditions was 
lower than in those targeting health system interventions. 
Interestingly, the proportion of stakeholder involvement 
has been quite constant between the years 2012 (5/15, 
33%) and 2014 (12/34, 34%) even though the amount of 
rapid reviews has increased substantially (table 2). There 
was, however, a remarkable increase in the proportion of 
stakeholder involvement for the year 2015 (22/32, 69%), 
but this was mostly due to the fact that a majority of CRD 
rapid reviews, which presented the highest proportion of 
stakeholder involvement, was indexed in 2015.
CRD rapid reviews turned out to have by far the highest 
proportion of reported stakeholder involvement. The 
types of stakeholders engaged were listed in the appendix 
of 26/30 articles, but it was not specified what they had 
specifically contributed to the review, for example, if their 
contribution had affected the final results and conclu-
sions of the reviews (table 3). One author mentioned in 
the review that the reason for involving stakeholders was 
to understand the clinical perspective.
We detected stakeholder involvement in 43% (13/30) 
of rapid reviews. In contrast to CRD rapid reviews, there 
was usually a small number of stakeholders engaged. They 
were involved at different phases, such as determining 
study characteristics, formulating the research question, 
within the review process in general, and less commonly 
in protocol writing, result synthesis and the interpretation 
of findings. One article involved stakeholder throughout 
all stages, in one case the phase of involvement was not 
specified. In total, 85% of the authors confirmed, that the 
stakeholders had significantly contributed to the review. 
Of these, 62% mentioned that involving stakeholders led 
to an increased impact of the review and enabled to focus 
on the needs of target groups, which made the review 
more relevant to for example, patients or policymakers. 
Stakeholders had commissioned one third of the rapid 
reviews or had asked for evidence. Only two of 13 authors 
(15%) did not mention any substantial effect. In two cases 
one of the funding sources was involved as stakeholder.
We identified stakeholder involvement in 20% (6/30) 
of non-Cochrane systematic reviews. In four cases the 
stakeholder involvement was confirmed via email, two 
articles mentioned the involvement of stakeholders. 
Only two types of stakeholders were reported: policy-
makers and researchers. If mentioned, all phases of 
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Table 1 Characteristics of included reviews by review type
Cochrane SR 
(%)
Non-Cochrane SR 
(%) RR (%) CRD RR (%) Total (%)
Random sample
(% of total per group)
30 (6) 30 (0.1) 30 (14) 30 (32) 120 (0.2)
Geographic location of the corresponding author (% of random sample)
Africa 2 (7) 0 0 0 2 (2)
Asia 5 (17) 3 (10) 1 (3) 0 9 (8)
Australia 3 (10) 5 (17) 2 (7) 0 10 (8)
Europe 11 (37) 13 (43) 13 (43) 2 (7) 39 (33)
North America 7 (23) 8 (27) 14 (47) 28 (93) 57 (48)
South America 2 (7) 1 (3) 0 0 3 (3)
Thematic focus
Prevention 11 (37) 5 (17) 4 (13) 7 (23) 27 (23)
Treatment 18 (60) 14 (47) 15 (50) 16 (53) 63 (53)
Health system 1 (3) 2 (7) 7 (23) 7 (23) 17 (14)
Community-based* 0 9 (30) 4 (13) 0 13 (11)
Funding
Governmental, institutional or WHO 30 (100) 30 (100) 30 (100) 30 (100) 120 (100)
Additional funding by company 0 0 1 (3) 0 1 (1)
Conflict of interest (COI)
Declared none 21 (70) 15 (50) 19 (63) 29 (97) 84 (70)
COI declared 9 (30) 3 (10) 3 (10) 0 15 (13)
Unmentioned 0 12 (40) 8 (27) 1 (3) 21 (18)
Study protocol
Yes, mentioned in article 30 (100) 5 (17) 4 (13) 1 (3) 40 (33)
Yes, mentioned in correspondence 0 8 (27) 9 (30) 0 17 (14)
No, confirmed by correspondence 0 2 (7) 4 (13) 0 6 (5)
Unmentioned 0 15 (50) 13 (43) 29 (97) 57 (48)
AMSTAR rating
Median (range) 11 (7, 11) 7 (3, 11) 4 (2, 10) 8 (5, 11) 8 (2, 11)
AMSTAR: measurement tool for the ‘assessment of the methodological quality of systematic reviews’, not applicable questions were not 
counted. Higher AMSTAR scores indicate higher quality.
*With exclusion of treatment or preventive interventions.
CRD, databases of the University of York, Center for Reviews and Dissemination; RR, rapid review;SR, systematic review.
involvement occurred about equally. A total 67% (4/6) 
study authors reported significant benefit from the stake-
holders’ contributions. One author mentioned that stake-
holder supported the researchers to understand different 
perspectives of the problem, and 33% (2/6) reported 
no effect. In one case, the stakeholder was involved as 
funding source.
Cochrane systematic reviews turned out to be the group 
with the smallest amount of stakeholder involvement. All 
stakeholder engagement was confirmed and specified by 
email. The types of stakeholders engaged were patients, 
caregivers, professional organisations and researchers. 
They were mostly involved for providing feedback 
during the review process, in one case they contributed 
in formulating the review question. One review involved 
stakeholders at all stages. A total of 50% (2/4) of the 
authors reported substantial benefit, the other 50% (2/4) 
reported no significant effect on study results or conclu-
sions. Two authors had involved stakeholders to make 
the review more relevant for its target audience, one 
author claimed that stakeholders helped him to refine 
the research question. One author involved stakeholders 
to get direct consumer feedback before publishing the 
review. No stakeholders were involved in funding.
DISCuSSIOn
The involvement of stakeholders varies by review type. 
Our findings suggest that rapid reviews tend to involve 
stakeholders more than twice as frequently than systematic 
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Table 2 General characteristics of stakeholder involvement (SI) by review type
Cochrane SR 
(%) (n=30)
Non-Cochrane SR 
(%) (n=30)
RR (%) 
(n=30)
CRD RR (%) 
(n=30)
Total (%) 
(N=120)
SI mentioned in article 2 (7) 2 (7) 6 (20) 28 (93) 38 (32)
SI only mentioned in correspondence 2 (7) 4 (13) 7 (23) 0 13 (11)
Total SI 4 (13) 6 (20) 13 (43) 28 (93) 51 (43)
SI per year
2011 0/5 (0) 0/1 (0) 0/3 (0) 0/0 (0) 0/9 (0)
2012 3/7 (43) 1/5 (20) 1/3 (33) 0/0 (0) 5/15 (33)
2013 0/9 (0) 0/6 (0) 3/5 (60) 9/10 (90) 12/30 (40)
2014 1/7 (14) 3/9 (30) 6/15 (40) 2/3 (67) 12/34 (35)
2015 0/2 (0) 2/9 (22) 3/4 (75) 17/17 (100) 22/32 (69)
Number of stakeholders involved per review (% of SI)
1 2 (50) 2 (33) 2 (15) 0 6 (12)
2–4 1 (25) 1 (17) 4 (31) 2 (7) 8 (16)
>4 1 (25) 3 (50) 4 (31) 26 (93) 34 (67)
Unspecified 0 0 3 (23) 0 3 (6)
Types of stakeholders (multiple roles possible) (% of SI)
Patients/consumers 2 (50) 0 2 (15) 5 (18) 9 (18)
Professional organisations 1 (25) 0 0 5 (18) 6 (12)
Caregivers 2 (50) 0 3 (23) 23 (82) 28 (55)
Researchers 1 (25) 3 (50) 2 (15) 0 6 (12)
Policymakers 0 3 (50) 4 (31) 3 (11) 10 (20)
Unspecified 0 0 2 (15) 4 (14) 6 (12)
Funding source (% of SI)
Governmental or institutional funding 4 (100) 6 (100) 13 (100) 28 (100) 51 (100)
Funding source involved as stakeholder 0 1 (17) 2 (15) 0 3 (6)
Thematic focus (% per review type per topic)
Prevention 0/11 (0) 0/5 (0) 1/4 (25) 6/7 (86) 7/27 (26)
Treatment 4/18 (22) 3/14 (21) 6/15 (40) 16/16 (100) 29/63 (46)
Health system 0/1 (0) 1/2 (50) 5/7 (71) 6/7 (86) 12/17 (71)
Community-based 0/0 (0) 2/9 (22) 1/4 (25) 0/0 (0) 3/13 (23)
CRD, databases of the University of York, Center for Reviews and Dissemination; RR, rapid review; SR, systematic review.
reviews. On average, they also involved a greater number 
of stakeholders per review. In addition, we detected 
considerable differences in the phases in which stake-
holders were involved. Rapid reviews involved them at 
very early stages of the review process, such as determining 
the intentional study characteristics or formulating the 
research question. Furthermore, it seemed to be much 
more common for policymakers, who were the most 
frequent group of stakeholders involved in rapid reviews, 
or other stakeholder groups, to substantially contribute 
to rapid reviews than to systematic reviews.
Of note, the majority of rapid and non-Cochrane 
systematic review authors reported that the involved 
stakeholders had positive and considerable effects on the 
study results, making the review more relevant for the 
targeted audience. However, the minority of rapid and 
non-Cochrane systematic review authors reporting no 
effect of stakeholder involvement on the review process, 
may illustrate that the stakeholders’ contribution to 
non-Cochrane systematic reviews was seen as an addi-
tional and welcomed feature to the review, but not as a 
substantial part. This shows the importance that within 
and between review types an information and experi-
ences exchange between researchers could benefit the 
stakeholder engagement.
A strength of this study is to provide an overview with 
its rather low amount of stakeholder engagement in the 
assessed review types despite known benefits regarding 
the use of evidence in policy and practice. With respect 
to the different procedures used by review types, the 
reported experiences of stakeholder engagement, for 
example, in rapid reviews, could further benefit and 
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Table 3 Engagement characteristics of stakeholder involvement (SI) by review type
Cochrane SR 
(%) (n=30)
Non-Cochrane SR 
(%) (n=30)
RR (%) 
(n=30)
CRD RR (%) 
(n=30)
Total (%) 
(N=120)
Stages of SI (multiple stages possible) (% of SI)
Research question 1 (25) 1 (17) 4 (31) 0 6 (12)
Study characteristics 0 0 6 (46) 0 6 (12)
Protocol writing 0 1 (17) 2 (15) 0 3 (6)
Review process 3 (75) 1 (17) 5 (38) 0 9 (18)
Interpretation of findings 0 1 (17) 1 (8) 0 2 (4)
Result synthesis 0 0 2 (15) 0 2 (4)
Multiple or all stages 1 (25) 2 (33) 1 (8) 28 (100) 32 (63)
Unspecified 0 2 (33) 1 (8) 0 3 (6)
Reasons mentioned for SI (% of SI)
Stakeholder commissioned/requested review 0 1 (17) 4 (31) 0 5 (10)
To get consumer feedback 1 (25) 0 0 0 1 (2)
To refine research question 1 (25) 0 0 0 1 (2)
To make the review more relevant for target 
audience
2 (50) 0 8 (62) 0 10 (20)
To understand clinical perspective 0 1 (17) 0 1 (4) 2 (4)
Unspecified 0 4 (67) 1 (7) 27 (96) 32 (63)
Effect of SI mentioned by authors (% of SI)
Substantial or positive effect 2 (50) 4 (67) 11 (85) 0 17 (33)
Negative effect 0 0 0 0 0
No effect mentioned 2 (50) 2 (33) 2 (15) 28 (100) 34 (67)
Explicit encouragement for involving stakeholders 
in further studies (% of reviews)
0 1 (3) 1 (3) 1 (3) 3 (2)
CRD, databases of the University of York, Center for Reviews and Dissemination; RR, rapid review; SR, systematic review.
facilitate stakeholder engagement in other review types, 
for example in systematic reviews.
One limitation of this study is the low response rate to 
our emails by contact authors. Given the fact that nearly 
half of our emails to study authors remained unanswered 
or could not be sent, the rate of unmentioned stakeholder 
involvement might still be higher than our numbers 
suggest. Of note, there was no considerable difference 
between systematic reviews and rapid reviews in the 
percentage of unmentioned stakeholder involvement.
Although our search is not very recent this article high-
lights the current situation and there is a call for action. 
Of course, an updated assessment might be needed in the 
years following.
Although when using a broad definition of the term 
‘stakeholder’ including everyone with a particular interest 
in the research topic (but who are not members of the 
primary research team), this term was not consistently 
used by contact authors. In their emails, some authors 
listed peer reviewers as stakeholders or one author erro-
neously mentioned members of the research team, who 
performed literature research and data extraction as 
stakeholders. In addition, interdisciplinary knowledge 
exchange is an important part of evidence-based research, 
but there is a difference whether experts from other 
fields were included as researchers in the study team or 
whether they were considered as stakeholders. We did 
not count any experts or peer reviewers as stakeholders. 
Furthermore, discussion is needed, whether the funding 
body of a review might contribute as a stakeholder and 
how a potentially associated conflict of interest could be 
avoided.
The reported involvement of stakeholders corre-
sponded with Cottrell et al who mentioned that stake-
holders might contribute to different study types and 
evidence phases.142 Based on, Keown et al143 concluded, 
that stakeholder involvement led to an increased rele-
vance and depth of review findings, more clarity in 
defining research questions, broader dissemination of 
their results and increased awareness of target groups. 
Although they mentioned that this engagement process 
required flexibility and might be resource-intensive and 
time-intensive, they nevertheless concluded that involving 
stakeholders facilitated implementation and should be 
indispensable for future research.
Although the overall proportion of stakeholder involve-
ment has not yet increased prominently in the past few 
years, there have still been considerable efforts in creating 
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standardised procedures for involving stakeholders in 
evidence synthesis. Keown et al identified five opportuni-
ties in the systematic review process, where potential stake-
holders could be engaged on a regular base.143 The CRD 
rapid reviews included were mainly performed by Health 
Quality Ontario (Canada) and routinely held expert 
panels, including physicians, caregivers and sometimes, 
consumer representatives and professional organisations. 
The fact that they included stakeholders on a regular 
basis might confirm, what Keown et al143 had already 
suggested: the engagement of audience members inter-
ested in or affected by the investigated topic definitively 
resulted in more benefits than limitations. We, therefore, 
suggest that future researcher involve stakeholders more 
broadly in the process of evidence synthesis, to increase 
the relevance and acceptance of the knowledge transfer. 
One example of an organisation ensuring that stake-
holders are involved in research is the James Lind Alli-
ance (http://www. jla. nihr. ac. uk).
In future, the reporting of stakeholder involvement 
should be improved and its effects better evaluated and 
communicated. Stakeholder engagement could also be 
included in reporting checklists of all review types.
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